Selected research
Market Structure
Global Amiodarone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Amiodarone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Amiodarone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Amiodarone include Shanghai Pharmaceuticals, Sanofi, Mylan Pharmaceuticals, North China Pharmaceutical Company, Harbin Pharmaceutical Group, Wyeth Pharmaceuticals (Pfizer), Sawai Pharmaceutical, Roemmers and Cipla Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Amiodarone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Amiodarone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Amiodarone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Amiodarone market size, projected growth trends, production technologies, key applications, and end-use industries.
Amiodarone Segment by Company
Shanghai Pharmaceuticals
Sanofi
Mylan Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Wyeth Pharmaceuticals (Pfizer)
Sawai Pharmaceutical
Roemmers
Cipla Pharmaceutical
Arrow Pharma Pty Ltd
Amiodarone Segment by Type
Injection Amiodarone
Tablet Amiodarone
Capsule Amiodarone
Amiodarone Segment by Application
Ventricular Tachycardia
Atrial Fibrillation
Cardiac Arrest
Others
Amiodarone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amiodarone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amiodarone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amiodarone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Amiodarone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amiodarone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amiodarone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Amiodarone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Injection Amiodarone
- Tablet Amiodarone
- Capsule Amiodarone
Applications
- Ventricular Tachycardia
- Atrial Fibrillation
- Cardiac Arrest
- Others
Companies covered
- Shanghai Pharmaceuticals
- Sanofi
- Mylan Pharmaceuticals
- North China Pharmaceutical Company
- Harbin Pharmaceutical Group
- Wyeth Pharmaceuticals (Pfizer)
- Sawai Pharmaceutical
- Roemmers
- Cipla Pharmaceutical
- Arrow Pharma Pty Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Amiodarone Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Amiodarone Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Amiodarone Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Amiodarone Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Amiodarone Market Dynamics
- 2.1 Amiodarone Industry Trends
- 2.2 Amiodarone Industry Drivers
- 2.3 Amiodarone Industry Opportunities and Challenges
- 2.4 Amiodarone Industry Restraints
3 Amiodarone Market by Manufacturers
- 3.1 Global Amiodarone Revenue by Manufacturers (2021-2026)
- 3.2 Global Amiodarone Sales by Manufacturers (2021-2026)
- 3.3 Global Amiodarone Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Amiodarone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Amiodarone Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Amiodarone Manufacturers, Product Type & Application
- 3.7 Global Amiodarone Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Amiodarone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Amiodarone Players Market Share by Revenue in 2025
- 3.8.3 2025 Amiodarone Tier 1, Tier 2, and Tier 3
4 Amiodarone Market by Type
- 4.1 Amiodarone Type Introduction
- 4.1.1 Injection Amiodarone
- 4.1.2 Tablet Amiodarone
- 4.1.3 Capsule Amiodarone
- 4.2 Global Amiodarone Sales by Type
- 4.2.1 Global Amiodarone Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Amiodarone Sales by Type (2021-2032)
- 4.2.3 Global Amiodarone Sales Market Share by Type (2021-2032)
- 4.3 Global Amiodarone Revenue by Type
- 4.3.1 Global Amiodarone Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Amiodarone Revenue by Type (2021-2032)
- 4.3.3 Global Amiodarone Revenue Market Share by Type (2021-2032)
5 Amiodarone Market by Application
- 5.1 Amiodarone Application Introduction
- 5.1.1 Ventricular Tachycardia
- 5.1.2 Atrial Fibrillation
- 5.1.3 Cardiac Arrest
- 5.1.4 Others
- 5.2 Global Amiodarone Sales by Application
- 5.2.1 Global Amiodarone Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Amiodarone Sales by Application (2021-2032)
- 5.2.3 Global Amiodarone Sales Market Share by Application (2021-2032)
- 5.3 Global Amiodarone Revenue by Application
- 5.3.1 Global Amiodarone Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Amiodarone Revenue by Application (2021-2032)
- 5.3.3 Global Amiodarone Revenue Market Share by Application (2021-2032)
6 Global Amiodarone Sales by Region
- 6.1 Global Amiodarone Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Amiodarone Sales by Region (2021-2032)
- 6.2.1 Global Amiodarone Sales by Region (2021-2026)
- 6.2.2 Global Amiodarone Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Amiodarone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Amiodarone Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Amiodarone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Amiodarone Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Amiodarone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Amiodarone Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Amiodarone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Amiodarone Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Amiodarone Revenue by Region
- 7.1 Global Amiodarone Revenue by Region
- 7.1.1 Global Amiodarone Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Amiodarone Revenue by Region (2021-2026)
- 7.1.3 Global Amiodarone Revenue by Region (2027-2032)
- 7.1.4 Global Amiodarone Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Amiodarone Revenue (2021-2032)
- 7.2.2 North America Amiodarone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Amiodarone Revenue (2021-2032)
- 7.3.2 Europe Amiodarone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Amiodarone Revenue (2021-2032)
- 7.4.2 Asia-Pacific Amiodarone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Amiodarone Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Amiodarone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Shanghai Pharmaceuticals
- 8.1.1 Shanghai Pharmaceuticals Company Information
- 8.1.2 Shanghai Pharmaceuticals Business Overview
- 8.1.3 Shanghai Pharmaceuticals Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Shanghai Pharmaceuticals Amiodarone Product Portfolio
- 8.1.5 Shanghai Pharmaceuticals Recent Developments
- 8.2 Sanofi
- 8.2.1 Sanofi Company Information
- 8.2.2 Sanofi Business Overview
- 8.2.3 Sanofi Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sanofi Amiodarone Product Portfolio
- 8.2.5 Sanofi Recent Developments
- 8.3 Mylan Pharmaceuticals
- 8.3.1 Mylan Pharmaceuticals Company Information
- 8.3.2 Mylan Pharmaceuticals Business Overview
- 8.3.3 Mylan Pharmaceuticals Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Mylan Pharmaceuticals Amiodarone Product Portfolio
- 8.3.5 Mylan Pharmaceuticals Recent Developments
- 8.4 North China Pharmaceutical Company
- 8.4.1 North China Pharmaceutical Company Company Information
- 8.4.2 North China Pharmaceutical Company Business Overview
- 8.4.3 North China Pharmaceutical Company Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 North China Pharmaceutical Company Amiodarone Product Portfolio
- 8.4.5 North China Pharmaceutical Company Recent Developments
- 8.5 Harbin Pharmaceutical Group
- 8.5.1 Harbin Pharmaceutical Group Company Information
- 8.5.2 Harbin Pharmaceutical Group Business Overview
- 8.5.3 Harbin Pharmaceutical Group Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Harbin Pharmaceutical Group Amiodarone Product Portfolio
- 8.5.5 Harbin Pharmaceutical Group Recent Developments
- 8.6 Wyeth Pharmaceuticals (Pfizer)
- 8.6.1 Wyeth Pharmaceuticals (Pfizer) Company Information
- 8.6.2 Wyeth Pharmaceuticals (Pfizer) Business Overview
- 8.6.3 Wyeth Pharmaceuticals (Pfizer) Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Wyeth Pharmaceuticals (Pfizer) Amiodarone Product Portfolio
- 8.6.5 Wyeth Pharmaceuticals (Pfizer) Recent Developments
- 8.7 Sawai Pharmaceutical
- 8.7.1 Sawai Pharmaceutical Company Information
- 8.7.2 Sawai Pharmaceutical Business Overview
- 8.7.3 Sawai Pharmaceutical Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Sawai Pharmaceutical Amiodarone Product Portfolio
- 8.7.5 Sawai Pharmaceutical Recent Developments
- 8.8 Roemmers
- 8.8.1 Roemmers Company Information
- 8.8.2 Roemmers Business Overview
- 8.8.3 Roemmers Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Roemmers Amiodarone Product Portfolio
- 8.8.5 Roemmers Recent Developments
- 8.9 Cipla Pharmaceutical
- 8.9.1 Cipla Pharmaceutical Company Information
- 8.9.2 Cipla Pharmaceutical Business Overview
- 8.9.3 Cipla Pharmaceutical Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Cipla Pharmaceutical Amiodarone Product Portfolio
- 8.9.5 Cipla Pharmaceutical Recent Developments
- 8.10 Arrow Pharma Pty Ltd
- 8.10.1 Arrow Pharma Pty Ltd Company Information
- 8.10.2 Arrow Pharma Pty Ltd Business Overview
- 8.10.3 Arrow Pharma Pty Ltd Amiodarone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Arrow Pharma Pty Ltd Amiodarone Product Portfolio
- 8.10.5 Arrow Pharma Pty Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Amiodarone Value Chain Analysis
- 9.1.1 Amiodarone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Amiodarone Production Mode & Process
- 9.2 Amiodarone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Amiodarone Distributors
- 9.2.3 Amiodarone Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst